Skip to main content
TipRanks
Go Ultimate75% OFF

Endonovo Therapeutics (ENDV) Q2 2019 Earnings Report

24 Followers

ENDV Q2 2019 EPS Results

Actual EPS
-$13.57
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$3.59

ENDV Q2 2019 Revenue Results

Actual Revenue
$62.73K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2019
Date
08/13/2019
Time
During Market Hours
Conference Call
Tuesday, August 13, 2019

Q2 2019 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2019 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2019 Earnings Call Summary

No earnings call summary is available for this earnings event.

ENDV Earnings History

ENDV earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 18, 20242024 (Q3)―-0.00033.33% (+0.00)
Aug 19, 20242024 (Q2)―-0.000-100.00% (-0.00)
Jun 17, 20242024 (Q1)―-0.000-125.00% (-0.01)
Nov 22, 20232023 (Q3)―-0―
Aug 21, 20232023 (Q2)―-0.00-0.0294.74% (+0.02)
Nov 21, 20222022 (Q3)―-0.00-0.0282.61% (+0.02)
Aug 22, 20222022 (Q2)―-0.02-0.0213.64% (+0.00)
May 19, 20222021 (Q4)―-0.03-0.0653.13% (+0.03)
May 19, 20222022 (Q1)―--0.06―
Nov 19, 20212021 (Q3)―-0.02-0.0765.15% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed